Terrestrial Energy | November 26, 2021
Terrestrial Energy USA was awarded a $3 million grant from the U.S. Department of Energy (DOE) to support licensing and commercialization of its Integral Molten Salt Reactor (IMSR), a Generation IV nuclear power plant. The largest of the DOE awards announced Nov. 18, the award supports modeling and simulation for the off-gas systems of the IMSR power plant, supporting the company’s regulatory program for U.S. NRC licensing.
“Advanced reactors will completely change the way we engineer, build, and operate nuclear reactors,” said Dr. Kathryn Huff, Principal Deputy Assistant Secretary for Nuclear Energy, in a press release announcing the awards. “These awards support technical and regulatory strides necessary for commercializing new carbon-free nuclear technologies poised to help our nation reach net-zero emissions by 2050.”
Terrestrial Energy is developing its IMSR Generation IV small modular reactor (SMR) power plant for commercial deployment in the late 2020s and is engaged with regulators in the United States and Canada. The Generation IV molten salt technology used by the IMSR power plant delivers a 50 percent increase in the thermal efficiency of electric power generation compared to power plants that use conventional – water-moderated-water-cooled –reactor technology. This provides a step-change improvement in the economics of nuclear power generation while preserving nuclear energy’s carbon-free and resiliency advantages over other energy sources.
“We value this grant and the Department of Energy’s support as we work to license and commercialize the IMSR nuclear power plant in the United States. It is encouraging that DOE sees the potential of Generation IV technologies and the IMSR. These grant programs support private companies as they work to deliver nuclear power technologies that can succeed in competitive global energy markets and deliver global net-zero goals. Technologies such as our IMSR Generation IV nuclear plants will produce reliable, cost-competitive heat and power without emissions, making them uniquely capable of competing with fossil fuels.”
Terrestrial Energy USA CEO Simon Irish
About Terrestrial Energy USA
Terrestrial Energy USA, based in Charlotte, NC, is developing the Integral Molten Salt Reactor (IMSR) for U.S. market deployment. The IMSR is a non-Light Water Reactor that uses Generation IV technology to generate electricity 50 percent more efficiently than conventional – water-moderated-water-cooled – nuclear reactor technology. The IMSR represents a step-change improvement in economics, versatility and functionality of nuclear power plants that is possible only with Generation IV technology. IMSR power plants will provide resilient, reliable, dispatchable, zero-carbon and cost-competitive electric power, as well as high-grade industrial heat for use in many industrial applications, such as chemical synthesis, hydrogen production and desalination, and in so doing extend the application of nuclear energy far beyond electric power markets. IMSR power plants have the potential to make important contributions to industrial competitiveness, energy security, and economic growth.
SuperCom | December 07, 2020
SuperCom a worldwide supplier of made sure about answers for the e-Government, IoT and Cybersecurity areas , reported today that it has made sure about another GPS monitoring contract in California. The contracting office is a privately owned business serving the legal administrations market.
The contract is for SuperCom's PureTrack cell phone GPS following items and is organized as a for every unit for each day rent model, with charging toward the finish of every month.
"With every new win, we become more confident in our business plan, our proprietary technology offering and our ability to add value in places where others cannot," stated Ordan Trabelsi, President of the Americas. "When new customers move over to our platform, they have concluded that the multitude of benefits they will receive simply outweigh the investment and risk inherent in such a change."
"We designed our products with new ideas on how to best serve the offender monitoring market. From the field based offender hardware to the backend monitoring software, we have implemented fresh and viable concepts that are being recognized through each new contract. And with each new contract, we expect an increase in our long-term recurring revenues and our global footprint in this market," concluded Ordan.
SuperCom's PureSecurity Suite is a best-of-breed electronic monitoring and following stage, which contains a complete arrangement of inventive highlights, including PDA combination, secure correspondence, progressed security, against alter components, finger impression biometrics, voice correspondence, one of a kind touch screens and expanded battery life.
Since 1988, SuperCom has been a global provider of traditional and digital identity solutions, providing advanced safety, identification and security solutions to governments and organizations, both private and public, throughout the world. Through its proprietary e-Government platforms and innovative solutions for traditional and biometrics enrollment, personalization, issuance and border control services, SuperCom has inspired governments and national agencies to design and issue secure Multi-ID documents and robust digital identity solutions to its citizens and visitors. SuperCom offers a unique all-in-one field-proven RFID & mobile technology and product suite, accompanied by advanced complementary services for various industries including healthcare and homecare, security and safety, community public safety, law enforcement, electronic monitoring, livestock monitoring, and building and access automation.
GlobalMed | October 19, 2021
GlobalMed, an international provider of telehealth solutions, today announced that its industry leading virtual health platform has earned the Defense Health Agency (DHA) Authority to Operate (ATO) on the U.S. Department of Defense (DoD) DHA Medical Community of Interest (Med COI) network.
GlobalMed's virtual health solutions are the first synchronous clinical virtual health technologies awarded an ATO. This much coveted certification enables GlobalMed to integrate their virtual health platform including carts, medical devices, software, and applications directly with the DHA's Med COI network, making their solutions available to integrate with MHS Genesis, the new patient-centric enterprise system designed to provide a single, continuous record of care for all DOD beneficiaries. In addition to providing medical care on the battlefield and at bases overseas (as well as on ships) DHA's network includes 721 military treatment facilities and 174,000 health care personnel, which provide health services to approximately 9.6 million beneficiaries.
"It has always been a personal priority to increase health care access for the members and families of the Army, Navy, Air Force, Marines, Space Force and Coast Guard. The Department of Defense is a huge healthcare provider and network security is a high priority. GlobalMed is committed to every aspect of security and compliance throughout our applications having recently completed our SOC 2 Type 2 examination with even more stringent security attestations on our road map. Our commitment to delivering unmatched performance, security and scalability extends beyond our government clients to those in the commercial enterprise space, giving physician groups and non-government hospitals an added measure of reassurance."
Joel E. Barthelemy, CEO and Vice Chairman of GlobalMed and a Marine Corps Reserve Veteran
DHA selected GlobalMed for its HIPAA-compliant virtual telemedicine platform that seamlessly and securely connects healthcare professionals and patients, regardless of location. GlobalMed is also the telehealth provider for the White House Medical Unit and has deployed their solutions across the VA hospitals and extension centers, and other U.S. Departments and Agencies.
GlobalMed powers the world's largest, most advanced virtual health platform that supports a patient at any point in the continuum of care. Providers are enabled with integrative software and data-capturing tools to deliver a complete and accurate patient encounter for evidence-based treatment and improved patient outcomes. Providers looking to manage capacity, reduce costs, and deliver responsible medicine, will get all they need from one platform.